TransMedics (TMDX) is up 10.4%, or $12.12 to $129.19.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics Group’s Earnings Call Highlights Robust Growth and Strategic Expansion
- TransMedics price target lowered to $140 from $145 at Piper Sandler
- TransMedics price target raised to $147 from $142 at Canaccord
- TransMedics Group Reports Strong Q3 2025 Results
- TransMedics Group: Strong Financial Performance and Positive Outlook Justify Buy Rating